Wegovy Podcast By Quiet. Please cover art

Wegovy

Wegovy

By: Quiet. Please
Listen for free

About this listen

 This series on Wegovy provides an in-depth look into the popular weight loss medication. The first episode introduces Wegovy, explaining its mechanism, clinical trials, and patient eligibility. The second episode delves into the benefits and potential risks, including effectiveness, side effects, and comparisons with other treatments. The final episode covers practical considerations such as usage, lifestyle integration, cost, and future developments. This series offers a comprehensive understanding for anyone considering Wegovy as a weight management solution.2024 Quiet. Please Hygiene & Healthy Living Physical Illness & Disease
Episodes
  • Wegovy Shakes Up Weight Loss Market: Novo Nordisk Cuts Ties with Telehealth Partner and Unveils Promising New Research

    Wegovy Shakes Up Weight Loss Market: Novo Nordisk Cuts Ties with Telehealth Partner and Unveils Promising New Research
    Jun 23 2025
    # Breaking News: Wegovy & Obesity Treatment Shake-up | Quiet Please Podcast

    Join veteran global reporter Alexandra Reeves as she unpacks the latest dramatic developments in the world of obesity treatment. In this must-listen episode, discover why pharmaceutical giant Novo Nordisk abruptly ended its partnership with telehealth provider Hims and Hers over allegations of counterfeit Wegovy products. Learn about groundbreaking clinical research unveiled at the American Diabetes Association summit, including Eli Lilly's bimagrumab combination therapy that preserves muscle while maximizing fat loss. Alexandra explores Wegovy's higher-dose formulation showing 21% average weight loss, important safety considerations, and what these developments mean for millions seeking effective obesity treatments. From corporate battles to scientific breakthroughs, this comprehensive analysis brings clarity to a medication that's reshaping modern medicine. Perfect for healthcare professionals, investors, and anyone interested in the future of weight management and pharmaceutical innovation.
    Show more Show less
    6 mins
  • Wegovy: The Revolutionary Weight Loss Drug Transforming Healthcare, Economy, and Society Beyond Expectations

    Wegovy: The Revolutionary Weight Loss Drug Transforming Healthcare, Economy, and Society Beyond Expectations
    Jun 21 2025
    # The Wegovy Revolution: How a Single Drug is Reshaping Healthcare, Economics, and Society

    Join host Alexandra Reeves as she explores the unprecedented impact of Wegovy beyond weight loss. This eye-opening episode reveals how Novo Nordisk's blockbuster medication is transforming multiple industries worldwide—from a patent protection lapse in Canada to its groundbreaking FDA approval for cardiovascular protection. Discover the latest developments in oral formulations, supply chain challenges, and emerging legal controversies surrounding this $28 billion phenomenon. Learn how Wegovy has grown from a simple weight management tool into a cultural force so powerful it's now worth more than Denmark's entire GDP. Essential listening for anyone interested in healthcare innovation, pharmaceutical business trends, or the evolving approach to obesity treatment in modern medicine.
    Show more Show less
    6 mins
  • Wegovy Revolutionizes Weight Loss: FDA Approves Groundbreaking Medication for Obesity and Heart Health Management

    Wegovy Revolutionizes Weight Loss: FDA Approves Groundbreaking Medication for Obesity and Heart Health Management
    Jun 16 2025
    # Wegovy: Transforming Weight Loss & Heart Health - with Alexandra Reeves

    Join veteran international correspondent Alexandra Reeves as she explores Wegovy, the groundbreaking medication revolutionizing obesity treatment and cardiovascular health. This episode dives into Wegovy's dual impact: significant weight loss benefits and its FDA approval for reducing serious heart problems in adults with cardiovascular disease and obesity.

    Discover how increased accessibility is changing lives as the FDA declares the Wegovy shortage resolved in 2025, while Novo Nordisk implements new pricing initiatives for self-pay patients. Alexandra examines the medication's growing popularity among teens, where prescriptions have increased by 50% in just one year.

    The episode provides crucial context on Wegovy's effectiveness, comparing its impressive 15% average weight loss to traditional options, while discussing the importance of lifestyle changes for optimal results. Looking ahead, learn about the potential game-changing oral formulation of Wegovy currently under FDA review.

    Perfect for healthcare professionals, individuals struggling with weight management, or anyone interested in the latest medical breakthroughs reshaping public health and personal wellness.
    Show more Show less
    6 mins
No reviews yet